THE COOPER HEALTH SYSTEM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Bezlotoxumab Efficacy and Tolerability in Cancer Patient

Phase 4

Conditions: Clostridium Difficile Infection Recurrence

Interventions: Drug: Bezlotoxumab Injection

First Posted Date: 2020-06-04

Last Posted Date: 2020-06-04

Lead Sponsor: The Cooper Health System

Target Recruit Count: 132

Registration Number: NCT04415918

Association of Hypertensive Disorder of Pregnancy With Sleep-disordered Breathing.

Conditions: Hypertensive Disorder of Pregnancy
Sleep-disordered Breathing

First Posted Date: 2019-10-15

Last Posted Date: 2020-01-22

Lead Sponsor: The Cooper Health System

Target Recruit Count: 100

Registration Number: NCT04126629

Locations: 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States

Time to Post-Anesthesia Neurological Evaluation With Three Different Anesthetic Techniques

Phase 4

Completed

Conditions: Carotid Artery Stenosis

Interventions: Drug: Remifentanil and Desflurane
Drug: Remifentanil, Propofol, and Desflurane
Drug: Remifentanil, Dexmedetomidine, and Desflurane

First Posted Date: 2019-06-24

Last Posted Date: 2022-04-06

Lead Sponsor: The Cooper Health System

Target Recruit Count: 21

Registration Number: NCT03996148

Locations: 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States

Talc Outpatient Pleurodesis With Indwelling Catheter

Not Applicable

Conditions: Malignant Pleural Effusion
Pleural Effusion
Pleural Diseases

Interventions: Device: Indwelling pleural catheter placement
Drug: Fentanyl Citrate
Drug: Talc Slurry
Device: Drainage collection bag

First Posted Date: 2019-06-04

Last Posted Date: 2019-06-04

Lead Sponsor: The Cooper Health System

Target Recruit Count: 124

Registration Number: NCT03973957

Locations: 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States

Caretaker vs. Blood Pressure Monitoring With Invasive Arterial Pressure Monitoring in Patients With Septic Shock

Active, not recruiting

Conditions: Blood Pressure

Interventions: Device: Caretaker

First Posted Date: 2019-05-01

Last Posted Date: 2024-02-07

Lead Sponsor: The Cooper Health System

Target Recruit Count: 40

Registration Number: NCT03933722

Locations: 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States

Caretaker vs. Routine Blood Pressure Sphygmomanometer

Completed

Conditions: Blood Pressure

Interventions: Device: Caretaker

First Posted Date: 2019-04-17

Last Posted Date: 2021-11-12

Lead Sponsor: The Cooper Health System

Target Recruit Count: 170

Registration Number: NCT03918486

Locations: 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States

Modafinil to Prevent Postoperative Cognitive Decline

Phase 2

Completed

Conditions: Postoperative Cognitive Dysfunction

Interventions: Drug: Preoperative modafinil + postoperative placebo
Drug: Preoperative placebo + postoperative placebo
Drug: Preoperative modafinil + postoperative modafinil

First Posted Date: 2019-04-16

Last Posted Date: 2023-09-29

Lead Sponsor: The Cooper Health System

Target Recruit Count: 137

Registration Number: NCT03914118

Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

Phase 4

Recruiting

Conditions: Robotic Lung Surgery

Interventions: Drug: Intercostal nerve block and wound infiltration with bupivacaine/epinephrine + dexamethasone
Drug: Intercostal nerve block and wound infiltration with liposomal bupivacaine

First Posted Date: 2019-04-08

Last Posted Date: 2021-11-12

Lead Sponsor: The Cooper Health System

Target Recruit Count: 34

Registration Number: NCT03906617

Locations: 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States

Prospective Study to Evaluate Mapleson Circuit With Monitored Anesthesia Care During Endobronchial Ultrasound (EBUS) Bronchoscopy

Not Applicable

Completed

Conditions: Adenopathy; Localized
Lung Cancer

Interventions: Procedure: Mapleson circuit and nasal trumpet

First Posted Date: 2019-01-24

Last Posted Date: 2019-01-24

Lead Sponsor: The Cooper Health System

Target Recruit Count: 200

Registration Number: NCT03815097

Non-Invasive CVP Method to Standard CVP Method

Not Applicable

Completed

Conditions: Central Venous Pressure

Interventions: Device: Non-Invasive CVP vs Standard CVP

First Posted Date: 2018-10-15

Last Posted Date: 2018-10-15

Lead Sponsor: The Cooper Health System

Target Recruit Count: 40

Registration Number: NCT03705299

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy